Virginia M. Stone

659 total citations
23 papers, 509 citations indexed

About

Virginia M. Stone is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Virginia M. Stone has authored 23 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 13 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in Virginia M. Stone's work include Viral Infections and Immunology Research (14 papers), Viral gastroenteritis research and epidemiology (10 papers) and Pancreatic function and diabetes (5 papers). Virginia M. Stone is often cited by papers focused on Viral Infections and Immunology Research (14 papers), Viral gastroenteritis research and epidemiology (10 papers) and Pancreatic function and diabetes (5 papers). Virginia M. Stone collaborates with scholars based in Sweden, Finland and United Kingdom. Virginia M. Stone's co-authors include Malin Flodström‐Tullberg, Heikki Hyöty, Minna M. Hankaniemi, Vesa P. Hytönen, Olli H. Laitinen, Amir‐Babak Sioofy‐Khojine, David M. Smith, Noel G. Morgan, Carol Lenaghan and Shalinee Dhayal and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Virginia M. Stone

21 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Virginia M. Stone Sweden 13 166 154 154 133 130 23 509
Sumei Zhang China 10 114 0.7× 56 0.4× 86 0.6× 194 1.5× 70 0.5× 24 540
Zhiming Huang China 13 44 0.3× 75 0.5× 88 0.6× 207 1.6× 76 0.6× 22 623
Nupur N. Gangopadhyay United States 11 58 0.3× 77 0.5× 106 0.7× 190 1.4× 52 0.4× 14 502
Jessica K. Fiege United States 14 102 0.6× 24 0.2× 124 0.8× 140 1.1× 36 0.3× 21 552
Aurélie Claës France 15 43 0.3× 97 0.6× 43 0.3× 338 2.5× 51 0.4× 22 847
Vi T. Dang Australia 11 75 0.5× 26 0.2× 158 1.0× 139 1.0× 45 0.3× 16 368
Huajun Zhang China 10 73 0.4× 102 0.7× 35 0.2× 145 1.1× 27 0.2× 31 488
Sophie Collot-Teixeira United Kingdom 9 41 0.2× 43 0.3× 109 0.7× 87 0.7× 43 0.3× 12 407
Miloni Rathod United States 6 84 0.5× 92 0.6× 60 0.4× 270 2.0× 226 1.7× 7 654
Małgorzata Wojtkowska Poland 15 63 0.4× 54 0.4× 32 0.2× 273 2.1× 31 0.2× 42 545

Countries citing papers authored by Virginia M. Stone

Since Specialization
Citations

This map shows the geographic impact of Virginia M. Stone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginia M. Stone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginia M. Stone more than expected).

Fields of papers citing papers by Virginia M. Stone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginia M. Stone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginia M. Stone. The network helps show where Virginia M. Stone may publish in the future.

Co-authorship network of co-authors of Virginia M. Stone

This figure shows the co-authorship network connecting the top 25 collaborators of Virginia M. Stone. A scholar is included among the top collaborators of Virginia M. Stone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginia M. Stone. Virginia M. Stone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parajuli, Anirudra, Virginia M. Stone, Emma Ringqvist, et al.. (2025). Frequent longitudinal blood microsampling and proteome monitoring identify disease markers and enable timely intervention in a mouse model of type 1 diabetes. Diabetologia. 68(10). 2277–2289.
2.
3.
Stone, Virginia M., Marta Butrym, Amir‐Babak Sioofy‐Khojine, et al.. (2022). Coxsackievirus B infections are common in Cystic Fibrosis and experimental evidence supports protection by vaccination. iScience. 25(10). 105070–105070. 3 indexed citations
4.
Sork, Helena, Virginia M. Stone, Maria Eldh, et al.. (2022). Proteome profiling of whole plasma and plasma-derived extracellular vesicles facilitates the detection of tissue biomarkers in the non-obese diabetic mouse. Frontiers in Endocrinology. 13. 971313–971313. 8 indexed citations
5.
6.
Stone, Virginia M., Minna M. Hankaniemi, Magdalena Mazur, et al.. (2020). Antibody Responses against Enterovirus Proteases are Potential Markers for an Acute Infection. Viruses. 12(1). 78–78. 8 indexed citations
7.
Hankaniemi, Minna M., Mo Baikoghli, Virginia M. Stone, et al.. (2020). Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine. Microorganisms. 8(9). 1287–1287. 15 indexed citations
8.
Stone, Virginia M., Minna M. Hankaniemi, Olli H. Laitinen, et al.. (2020). A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates. Science Advances. 6(19). eaaz2433–eaaz2433. 57 indexed citations
9.
Khan, Dawood, Virginia M. Stone, Annie Hasib, et al.. (2019). Short-term CFTR inhibition reduces islet area in C57BL/6 mice. Scientific Reports. 9(1). 11244–11244. 12 indexed citations
10.
Hankaniemi, Minna M., Virginia M. Stone, Amir‐Babak Sioofy‐Khojine, et al.. (2019). Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine. Antiviral Research. 171. 104595–104595. 21 indexed citations
11.
Hankaniemi, Minna M., Virginia M. Stone, Amir‐Babak Sioofy‐Khojine, et al.. (2019). A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine. Vaccine. 37(40). 5962–5971. 18 indexed citations
12.
Laiho, Jutta E., Sarah J. Richardson, Virginia M. Stone, et al.. (2018). A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses. Scientific Reports. 8(1). 33–33. 20 indexed citations
13.
Laitinen, Olli H., Emma Svedin, Minna M. Hankaniemi, et al.. (2018). New Coxsackievirus 2Apro and 3Cpro protease antibodies for virus detection and discovery of pathogenic mechanisms. Journal of Virological Methods. 255. 29–37. 14 indexed citations
14.
Stone, Virginia M., Minna M. Hankaniemi, Emma Svedin, et al.. (2017). A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. Diabetologia. 61(2). 476–481. 49 indexed citations
15.
Hankaniemi, Minna M., Olli H. Laitinen, Virginia M. Stone, et al.. (2017). Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model. Vaccine. 35(30). 3718–3725. 30 indexed citations
16.
Laiho, Jutta E., Sami Oikarinen, Maarit Oikarinen, et al.. (2015). Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technology. Journal of Clinical Virology. 69. 165–171. 12 indexed citations
17.
Bjursell, Mikael, Xiufeng Xu, Therése Admyre, et al.. (2014). The Beneficial Effects of n-3 Polyunsaturated Fatty Acids on Diet Induced Obesity and Impaired Glucose Control Do Not Require Gpr120. PLoS ONE. 9(12). e114942–e114942. 62 indexed citations
18.
Stone, Virginia M., Shalinee Dhayal, Katy J. Brocklehurst, et al.. (2014). GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans. Diabetologia. 57(6). 1182–1191. 106 indexed citations
19.
Stone, Virginia M., Shalinee Dhayal, David M. Smith, et al.. (2011). The cytoprotective effects of oleoylethanolamide in insulin‐secreting cells do not require activation of GPR119. British Journal of Pharmacology. 165(8). 2758–2770. 21 indexed citations
20.
Carroll, Camille, et al.. (2010). POMD11 Cannabinoids are neuroprotective in a human cell culture model of Parkinson's disease. Journal of Neurology Neurosurgery & Psychiatry. 81(11). e60–e60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sumei Zhang Breakdown of academic impact, for papers by Zhiming Huang Breakdown of academic impact, for papers by Nupur N. Gangopadhyay Breakdown of academic impact, for papers by Jessica K. Fiege Breakdown of academic impact, for papers by Aurélie Claës Breakdown of academic impact, for papers by Vi T. Dang Breakdown of academic impact, for papers by Huajun Zhang Breakdown of academic impact, for papers by Sophie Collot-Teixeira Breakdown of academic impact, for papers by Miloni Rathod Breakdown of academic impact, for papers by Małgorzata Wojtkowska
Rankless by CCL
2026